Company profile: Apicore
1.1 - Company Overview
Company description
- Provider of process R&D and active pharmaceutical ingredient (API) manufacturing services for the pharmaceutical industry worldwide, specializing in difficult-to-synthesize, high-value, and niche specialty APIs, serving customers in the generic medicine industry.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Apicore
Albuquerque Neuroscience
HQ: United States
Website
- Description: Provider of high-quality research focused on human diseases of the central nervous system (CNS), particularly psychiatric disorders; specialized in CNS diseases and general medical conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Albuquerque Neuroscience company profile →
Reverba
HQ: United States
Website
- Description: Provider of patient engagement solutions for pharmaceutical and biotechnology companies, including clinical patient engagement programs powered by the reverbaBRIDGE platform, global clinical trial optimization with patient-centered approaches and real-time data insights, expert recruitment, tech-enabled relationship management and automation, and total compliance with HIPAA, GDPR, and FDA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reverba company profile →
Paradigm Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paradigm Therapeutics company profile →
Just Evotec Biologics
HQ: United States
Website
- Description: Provider of integrated technologies and services to accelerate biotherapeutics development and reduce manufacturing costs, including continuous manufacturing platforms for antibodies, next-generation biologics and biosimilars within cGMP facilities; a US/EU global network for antibody discovery, cell line, analytical and process development; cGMP biomanufacturing from early clinical to commercial; and partnership opportunities from discovery to market supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Just Evotec Biologics company profile →
Adalvo
HQ: Malta
Website
- Description: Provider of B2B pharmaceutical products and services, part of Alvogen Group and powered by Alvogen and Alvotech. Offers 90+ specialty generic small-molecule products across Oncology, Women’s Health, Cardiovascular and CNS; 15+ value-added 505(b)(2) CNS therapies; and 8+ peptide products for Rare Diseases and Diabetes. Develops Fidaxomicin 200 mg tablets, Ethinylestradiol/Drospirenone, and Dimethyl Fumarate for RRMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adalvo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Apicore
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Apicore
2.2 - Growth funds investing in similar companies to Apicore
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Apicore
4.2 - Public trading comparable groups for Apicore
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →